Merrimack Pharmaceuticals, Inc. Made Big Gain
Mon, Oct 17, 2022 at 09:10 PM
Merrimack Pharmaceuticals, Inc. (MACK:NASDAQ) jumped higher at $4.41, a gain of 32%. On Mon, Oct 17, 2022, MACK:NASDAQ hit a New 2-Week High of $4.41. From Mon, Oct 03, 2022, the stock recorded 50.00% Up Days and 54.55% Green Days
About Merrimack Pharmaceuticals, Inc. (MACK:NASDAQ)
Merrimack Pharmaceuticals Inc is a biotechnology company. It discovers, develops, and commercializes innovative medicines consisting of novel therapeutics paired with diagnostics to treat various types of cancer.
Top 10 Gainers:
- Acorda Therapeutics, Inc. (ACOR:NASDAQ), 163.82%
- Inpixon (INPX:NASDAQ), 90.59%
- FedNat Holding Company (FNHC:NASDAQ), 60.35%
- Oblong Inc. (OBLG:NASDAQ), 54.38%
- Archaea Energy Inc. Class A (LFG:NYSE), 54.15%
- Babylon Holdings Limited Class A (BBLN:NYSE), 43.73%
- OPAL Fuels Inc. (OPAL:NASDAQ), 40.92%
- American Virtual Cloud Technologies, Inc. (AVCT:NASDAQ), 39.13%
- Statera Biopharma Inc. (STAB:NASDAQ), 35.22%
- Merrimack Pharmaceuticals, Inc. (MACK:NASDAQ), 32.04%